Erika A. Eksioglu

The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype

Ashley A. Basiorka, Kathy L. McGraw, Erika A. Eksioglu et al. · Blood · 2016 · 346 citations · Full text

Life Sciences, Immunology, Molecular Biology +14

Induction of myelodysplasia by myeloid-derived suppressor cells

Xianghong Chen, Erika A. Eksioglu, Junmin Zhou et al. · Journal of Clinical Investigation · 2013 · 312 citations · Full text

Life Sciences, Cell Biology, Immunology +15

TGF-β–inducible microRNA-183 silences tumor-associated natural killer cells

Sarah S. Donatelli, Junmin Zhou, Danielle L. Gilvary et al. · Proceedings of the National Academy of Sciences · 2014 · 214 citations · Full text

Life Sciences, Immunology, Oncology +17

<i>TP53</i> mutations in myelodysplastic syndromes and secondary AML confer an immunosuppressive phenotype

David A. Sallman, Amy F. McLemore, Amy L. Aldrich et al. · Blood · 2020 · 188 citations · Full text

Medicine, Hematology, Molecular Genetics +13

Icariin and its derivative, ICT, exert anti-inflammatory, anti-tumor effects, and modulate myeloid derived suppressive cells (MDSCs) functions

Junmin Zhou, Jinfeng Wu, Xianghong Chen et al. · International Immunopharmacology · 2011 · 181 citations · Full text

Medicine, Immunology, Pharmacology +14